Specific patient-reported outcome measures for Parkinson’s disease: analysis and applications

References

• World Health Organization. International Classification of Functioning, Disability and Health (ICF). WHO Press, Geneva, Switzerland (2001).
   Google Scholar
• Acquadro C, Berzon R, Dubois D et al. Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health6(5), 522–531 (2003).
   PubMed Web of Science ®Google Scholar
• Sweeney K, Kernick D. Clinical evaluation: constructing a new model for post-normal medicine. J. Eval. Clin. Pract.8(2), 131–138 (2002).
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Curr. Neurol. Neurosci. Rep.5(4), 275–283 (2005).
   PubMedGoogle Scholar
• Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol.5(3), 235–245 (2006).
   PubMed Web of Science ®Google Scholar
• Schapira AHV. Treatment options in the modern management of Parkinson disease. Arch. Neurol.64(8), 1083–1088 (2007).
   PubMed Web of Science ®Google Scholar
• Tolosa E, Katzenschlager R. Pharmacological management of Parkinson’s disease. In: Parkinson’s Disease & Movement Disorders. Jankovic J, Tolosa E (Eds). Lippincott Williams & Wilkins, PA, USA, 110–145 (2007).
   Google Scholar
• Fahn S, Elton RL; Members of the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Recent Developments in Parkinson’s Disease (Volume 2). Fahn S, Marsden CD, Calne DB, Goldstein M (Eds). Macmillan Healthcare Information, NJ, USA 153–164 (1987).
   Google Scholar
• Marinus J, Visser M, Stiggelbout AM et al. A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA. J. Neurol. Neurosurg. Psychiatry75(3), 388–395 (2004).
   PubMed Web of Science ®Google Scholar
• Marinus J, Visser M, Verwey NA et al. Assessment of cognition in Parkinson’s disease. Neurology61(9), 1222–1228 (2003).
   PubMed Web of Science ®Google Scholar
• Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, van Hilten JJ. Assessment of psychiatric complications in Parkinson’s disease: the SCOPA–PC. Mov. Disord.22(15), 2221–2228 (2007).
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Martinez-Martin P, Brown RG et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov. Disord.22(13), 1901–1911 (2007).
   PubMed Web of Science ®Google Scholar
• Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson’s disease. In: Third Symposium on Parkinson’s Disease. Gillingham FJ, Donaldson IML (Eds). E and S Livingstone, Edinburgh, UK, 152–157 (1969).
   Google Scholar
• Martinez-Martin P, Gil-Nagel A, Morlan-Gracia L et al. Intermediate scale for assessment of Parkinson’s disease. Characteristics and structure. Parkinsonism Relat. Disorders1(2), 97–102 (1995).
   PubMedGoogle Scholar
• Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson’s Disease Rating Scale. Mov. Disord.11(2), 185–192 (1996).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Benito-Leon J, Alonso F et al. Patients’, doctors’ and caregivers’ assessment of disability using the UPDRS-ADL Section: are these ratings interchangeable? Mov. Disord.18(9), 985–992 (2003).
   PubMed Web of Science ®Google Scholar
• Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B. Patient-reported outcomes: conceptual issues. Value Health10(Suppl. 2), S66–S75 (2007).
   PubMed Web of Science ®Google Scholar
• Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J. Clin. Epidemiol.61(2), 102–109 (2008).
   PubMed Web of Science ®Google Scholar
• Bowling A. Measuring Health. A Review of Quality of Life Measurement Scales (3rd Edition). Open University Press, Berkshire, UK, 1–9 (2005).
   Google Scholar
• Martínez-Martín P, Benito-León J, Alonso F, Catalán MJ, Pondal M, Zamarbide I. Health-related quality of life evaluation by proxy in Parkinson’s disease: approach using PDQ-8 and EuroQoL-5D. Mov. Disord.19(3), 312–318 (2004).
   PubMed Web of Science ®Google Scholar
• Fleming A, Cook KF, Nelson ND, Lai EC. Proxy reports in Parkinson’s disease: caregiver and patient self-reports of quality of life and physical activity. Mov. Disord.20(11), 1462–1468 (2005).
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P. An introduction to the concept of “quality of life in Parkinson’s disease”. J. Neurol.245(Suppl. 1), 2–5 (1998).
   PubMedGoogle Scholar
• Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: a metaanalysis. Qual. Life Res.8(5), 447–459 (1999).
   PubMed Web of Science ®Google Scholar
• Moons P, Budts W, De Geest S. Critique on the conceptualisation of quality of life: a review and evaluation of different conceptual approaches. Int. J. Nurs. Stud.43(7), 891–901 (2006).
   PubMed Web of Science ®Google Scholar
• Den Oudsten BL, Van Heck GL, De Vries J. Quality of life and related concepts in Parkinson’s disease: a systematic review. Mov. Disord.22(11), 1528–1537 (2007).
   PubMed Web of Science ®Google Scholar
• Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual. Life Res.11(3), 193–205 (2002).
   PubMed Web of Science ®Google Scholar
• Nunnally JC, Bernstein IH. Psychometric Theory. McGraw-Hill, NY, USA (1994)
   Google Scholar
• Streiner DL, Norman GR. Health measurement scales. A Practical Guide To Their Development And Use (3rd Edition). Oxford University Press, Oxford, UK (2003).
   Google Scholar
• deVellis RF. Classical test theory. Med. Care44(11 Suppl. 3), S50–S59 (2006).
   PubMed Web of Science ®Google Scholar
• Hobart J. Measuring disease impact in disabling neurological conditions: are patients’ perspectives and scientific rigor compatible? Curr. Opin. Neurol.15(6), 721–724 (2002).
   PubMed Web of Science ®Google Scholar
• Hobart JC, Cano SJ, Zajicek JP, Thompson AJ. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol.6(12), 1094–105 (2007).
   PubMed Web of Science ®Google Scholar
• Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of Item Response Theory. Sage Publications, CA, USA (1991).
   Google Scholar
• Fayers PM, Machin D. Quality of life. The Assessment, Analysis And Interpretation Of Patient-reported Outcomes (2nd Edition). John Wiley & Sons Ltd, Chichester, UK (2007).
   Google Scholar
• Rasch G. Probabilistic Models For Some Intelligence And Attainment Tests. Danmarks Paedogogiske Institut, Copenhagen, Denmark (1960).
   Google Scholar
• Lai J, Cella D, Chang CH, Bode RK, Heinemann AW. Item banking to improve, shorten and computerize self-reported fatigue: An illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual. Life Res.12(5), 485–501 (2003).
   PubMed Web of Science ®Google Scholar
• Petersen MA, Groenvold M, Bjorner JB et al. Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire. Qual. Life Res.12(4), 373–385 (2003).
   PubMed Web of Science ®Google Scholar
• Fliege H, Becker J, Walter OB, Bjorner JB, Klapp BF, Rose M. Development of a computer-adaptive test for depression (D-CAT). Qual. Life Res.14(10), 2277–2291 (2005).
   PubMed Web of Science ®Google Scholar
• Cook KF, Monahan PO, McHorney CA. Delicate balance between theory and practice: health status assessment and item response theory. Med. Care41(5), 571–574 (2003).
   PubMedGoogle Scholar
• Andrich A. Controversy and the Rasch Model. A Characteristic of Incompatible Paradigms? Med. Care42(Suppl. 1), 7–16 (2004).
   PubMed Web of Science ®Google Scholar
• Fayers OM, Hand DJ, Bjordal K, Groenvold M. Causal indicators in quality of life research. Qual. Life Res.6(5), 393–406 (1997).
   PubMed Web of Science ®Google Scholar
• Marx GR, Bombardier C, Hogg-Johnson S, Wright JG. Clinimetrics and psychometric strategies for development of a health measurement scale. J. Clin. Epidemiol.52(2), 105–111 (1999).
   PubMed Web of Science ®Google Scholar
• Streiner DL. Clinimetrics vs. psychometrics: an unnecessary distinction. J. Clin. Epidemiol.56(12), 1142–1145 (2003).
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Rafanelli C. Psychometric theory is an obstacle to the progress of clinical research. Psychother. Psychosom.73(3), 145–148 (2004)
   PubMed Web of Science ®Google Scholar
• Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for clinical trials. Health Technol. Assess.2(14), 1–74 (1998).
   PubMedGoogle Scholar
• Lohr KN. Health outcomes methodology symposium. Summary and recommendations. Med. Care.38(Suppl. 9), 194–208 (2000).
   Web of Science ®Google Scholar
• Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: the example of health-related quality of life – a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf. J.36, 209–238 (2002).
   Web of Science ®Google Scholar
• Hyland ME. A brief guide to the selection of quality of life instrument. Health Qual. Life Outcomes.1, 24 (2003).
   PubMedGoogle Scholar
• Terwee C, Bot SDM, de Boer RM et al. Quality criteria were proposed for measurement properties of health status questionnaires. J. Clin. Epidemiol.60(1), 34–42 (2007).
   PubMed Web of Science ®Google Scholar
• Biemans MA, Dekker J, van der Woude LH. The internal consistency and validity of the Self-Assessment Parkinson’s Disease Disability Scale. Clin. Rehabil.15(2), 221–228 (2001).
   PubMed Web of Science ®Google Scholar
• Stallibrass C, Sissons P, Chalmers C. Randomized controlled trial of the Alexander technique for idiopathic Parkinson’s disease. Clin. Rehabil.16(7), 695–708 (2002).
   PubMed Web of Science ®Google Scholar
• Hobson JP, Edwards NI, Meara RJ. The Parkinson’s Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson’s disease. Clin. Rehabil.15(3), 241–246 (2001).
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol.46(10), 1121–1123 (1989).
   PubMed Web of Science ®Google Scholar
• Lou JS, Kearns G, Oken B, Sexton G, Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson’s disease. Mov. Disord.16(2), 190–196 (2001).
   PubMed Web of Science ®Google Scholar
• Smets EM, Grassen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res.39(3), 315–325 (1995).
   PubMed Web of Science ®Google Scholar
• Brown RG, Dittner A, Findley L, Wessely SC. The Parkinson fatigue scale. Parkinsonism Relat. Disord.11(1), 49–55 (2005).
   PubMed Web of Science ®Google Scholar
• Grace J, Mendelsohn A, Friedman JH. A comparison of fatigue measures in Parkinson’s disease. Parkinsonism Relat. Disord.13(7), 443–445 (2007).
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Pal S, Dimarco A et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry73(6), 629–635 (2002).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Salvador C, Menendez-Guisasola L et al. Parkinson’s Disease Sleep Scale: validation study of a Spanish version. Mov. Disord.19(10), 1226–1232 (2004).
   PubMed Web of Science ®Google Scholar
• Tse W, Liu Y, Barthlen GM et al. Clinical usefulness of the Parkinson’s Disease Sleep scale. Parkinsonism Relat. Disord.11(5), 317–321 (2005).
   PubMed Web of Science ®Google Scholar
• Gómez-Esteban JC, Zarranz JJ, Lezcano E et al. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson’s disease. Mov. Disord.21(7), 983–988 (2006).
   PubMed Web of Science ®Google Scholar
• Dhawan V, Dhoat S, Williams AJ et al. The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD). A comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J. Neurol. Sci.248(1–2), 158–162 (2006).
   PubMed Web of Science ®Google Scholar
• Suzuki K, Okuma Y, Hattori N et al. Characteristics of sleep disturbances in Japanese patients with Parkinson’s disease. A study using Parkinson’s disease sleep scale. Mov. Disord.22(9), 1245–1251 (2007).
   PubMed Web of Science ®Google Scholar
• Gómez-Esteban JC, Zarranz JJ, Tijero B et al. Restless legs syndrome in Parkinson’s disease. Mov. Disord.22(13), 1912–1916 (2007).
   PubMed Web of Science ®Google Scholar
• Suzuki K, Miyamoto M, Miyamoto T et al. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson’s disease. Parkinsonism Relat. Disord. (2008) (Epub ahead of print).
   Google Scholar
• Abe K, Hikita T, Sakoda S. Sleep disturbances in Japanese patients with Parkinson’s disease – comparing with patients in the UK. J. Neurol. Sci.234(1–2), 73–78 (2005).
   PubMed Web of Science ®Google Scholar
• Happe S, Baier PC, Helmschmied K, Meller J, Tatsch K, Paulus W. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson’s disease. J. Neurol.254(8), 1037–1043 (2007).
   PubMed Web of Science ®Google Scholar
• Hjort N, Østergaard K, Dupont E. Improvement of sleep quality in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus. Mov. Disord.19(2), 196–199 (2004) .
   PubMed Web of Science ®Google Scholar
• Romigi A, Stanzione P, Marciani MG et al. Effect of cabergoline added to levodopa treatment on sleep–wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study. J. Neural Transm.113(12), 1909–1913 (2006).
   PubMed Web of Science ®Google Scholar
• Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F. Health-related quality of life and sleep disorders in Parkinson’s disease. Neurol. Sci.24(3), 209–210 (2003).
   PubMed Web of Science ®Google Scholar
• Tanasanvimon S, Ayuthaya NI, Phanthumchinda K. Modified Parkinson’s Disease Sleep Scale (MPDSS) in Thai Parkinson’s disease patients. J. Med. Assoc. Thai.90(11), 2277–2283 (2007)
   PubMedGoogle Scholar
• Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep26(8), 1049–1054 (2003).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Cubo-Delgado E, Aguilar-Barbera M et al. A pilot study on a specific measure for sleep disorders in Parkinson’s disease: SCOPA–Sleep. Rev. Neurol.43(11), 577–583 (2006).
   PubMed Web of Science ®Google Scholar
• Verbaan D, van Rooden SM, Visser M, Marinus J, van Hilten JJ. Nighttime sleep problems and daytime sleepiness in Parkinson’s disease. Mov. Disord.23(1), 35–41 (2008).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Visser M, Rodriguez-Blazquez C et al. SCOPA–Sleep and PDSS: two scales for assessment of sleep disorder in Parkinson’s disease. Mov. Disord. (2008) (Epub ahead of print).
   Google Scholar
• Pacchetti C, Manni R, Zangaglia R et al. A questionnaire on sleep and mental disorders in Parkinson’s disease (QSMDPD): development and application of a new screening tool. Funct. Neurol.19(2), 83–99 (2004).
   PubMed Web of Science ®Google Scholar
• Perez Lloret S, Pirán Arce G, Rossi M, Caivano Nemet ML, Salsamendi P, Merello M. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson’s disease. Mov. Disord.22(1), 107–111 (2007).
   PubMed Web of Science ®Google Scholar
• Manor Y, Giladi N, Cohen A, Fliss DM, Cohen JT. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson’s disease. Mov. Disord.22(13), 1917–1921 (2007).
   PubMed Web of Science ®Google Scholar
• Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with parkinsonism. Parkinsonism Relat. Disord.6(3), 165–170 (2000).
   PubMed Web of Science ®Google Scholar
• Brichetto G, Pelosin E, Marchese R, Abbruzzese G. Evaluation of physical therapy in parkinsonian patients with freezing of gait: a pilot study. Clin. Rehabil.20(1), 31–35 (2006)
   PubMed Web of Science ®Google Scholar
• Moore O, Peretz C, Giladi N. Freezing of gait affects quality of life of peoples with Parkinson’s disease beyond its relationships with mobility and gait. Mov. Disord.22(15), 2192–2195 (2007).
   PubMed Web of Science ®Google Scholar
• Amboni M, Cozzolino A, Longo K, Picillo M, Barone P. Freezing of gait and executive functions in patients with Parkinson’s disease. Mov. Disord.23(3), 395–400 (2008).
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Shinotoh H, Uchiyama T et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton. Neurosci.92(1–2), 76–85 (2001).
   PubMed Web of Science ®Google Scholar
• Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA–AUT. Mov. Disord.19(11), 1306–1312 (2004).
   PubMed Web of Science ®Google Scholar
• Idiaquez J, Benarroch EE, Rosales H, Milla P, Ríos L. Autonomic and cognitive dysfunction in Parkinson’s disease. Clin. Auton. Res.17(2), 93–98 (2007).
   PubMed Web of Science ®Google Scholar
• Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology69(4), 333–341 (2007).
   PubMed Web of Science ®Google Scholar
• Stacy M, Bowron A, Guttman M et al. Identification of motor and nonmotor wearing-off in Parkinson’s disease: comparison of a patient questionnaire versus a clinician assessment. Mov. Disord.20(6), 726–733 (2005).
   PubMed Web of Science ®Google Scholar
• Stacy M, Hauser R, Oertel W et al. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clin. Neuropharmacol.29(6), 312–321 (2006).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Tolosa E, Hernandez B, Badia X. The Patient Card questionnaire to identify wearing-off in Parkinson disease. Clin. Neuropharmacol.30(5), 266–275 (2007).
   PubMed Web of Science ®Google Scholar
• Stacy M, Hauser R. Development of a patient questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease. Neural Transm.114(2), 211–217 (2007).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Tolosa E, Hernandez B, Badia X; ValidQUICK Study Group Members. Validation of the “QUICK” questionnaire – a tool for diagnosis of “wearing-off” in patients with Parkinson’s disease. Mov. Disord.23(6), 830–836 (2008).
   PubMed Web of Science ®Google Scholar
• Santens P, de Noordhout AM; Belgian EODWO Study Group. Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson’s disease using a dedicated questionnaire: a Belgian multicenter survey. Acta Neurol. Belg.106(3), 137–141 (2006).
   PubMed Web of Science ®Google Scholar
• Azulay JP, Durif F, Rogez R, Tranchant C, Bourdeix I, Rerat K. Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations. Rev. Neurol. (Paris)164(4), 354–362 (2008).
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Martinez-Martin P, Schapira AH et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov. Disord.21(7), 916–923 (2006).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Schapira AH, Stocchi F et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting: study using nonmotor symptoms questionnaire in 545 patients. Mov. Disord.22(11), 1623–1629 (2007).
   PubMed Web of Science ®Google Scholar
• Cheon SM, Ha MS, Park MJ, Kim JW. Nonmotor symptoms of Parkinson’s disease: prevalence and awareness of patients and families. Parkinsonism Relat. Disord.14(4), 286–290 (2008).
   PubMed Web of Science ®Google Scholar
• Perez Lloret S, Rossi M, Cardinali DP, Merello M. Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson’s disease (NMSQuest). Parkinsonism Relat. Disord. (2008).
   PubMedGoogle Scholar
• Katzenschlager R, Schrag A, Evans A et al. Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure. Neurology69(6), 555–563 (2007).
   PubMed Web of Science ®Google Scholar
• Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov. Disord.18(7), 738–750 (2003).
   PubMed Web of Science ®Google Scholar
• Goetz CG, Fahn S, Martinez-Martin P et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format and clinimetric testing plan. Mov. Disord.22(1), 41–47 (2007).
   PubMed Web of Science ®Google Scholar
• Hauser RA, Friedlander J, Zesiewicz TA et al. A home diary to assess functional status in patients with Parkinson’s disease with motor fluctuations and dyskinesia. Clin. Neuropharmacol.23(2), 75–81 (2000).
   PubMed Web of Science ®Google Scholar
• Parkinson Study Group. Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. Arch. Neurol.58(10), 1660–1668 (2001).
   PubMed Web of Science ®Google Scholar
• Marinus J, Visser M, Stiggelbout AM et al. Activity-based diary for Parkinson’s disease. Clin. Neuropharmacol.25(1), 43–50 (2002).
   PubMed Web of Science ®Google Scholar
• Hauser RA, Deckers F, Lehert P. Parkinson’s disease home diary: further validation and implications for clinical trials. Mov. Disord.19(12), 1409–1413 (2004).
   PubMed Web of Science ®Google Scholar
• Reimer J, Grabowski M, Lindvall O, Hagell P. Use and interpretation of on/off diaries in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry75(3), 396–400 (2004).
   PubMed Web of Science ®Google Scholar
• Hauser RA, Russ H, Haeger DA, Bruguiere-Fontenille M, Müller T, Wenning GK. Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease. Clin. Neuropharmacol.29(6), 322–330 (2006)
   PubMed Web of Science ®Google Scholar
• Stone AA, Shiffman S, Schwartz JE, Braderick JE, Hufford MR. Patient non-compliance with paper diaries. BMJ324(7347), 1193–1194 (2002).
   PubMed Web of Science ®Google Scholar
• Jenkinson C, PetoV, Fitzpatrick R, Greenhall R, Hyman N. Self-reported functioning and well-being in patients with Parkinson’s disease: comparison of the Short-form Health Survey (SF-36) and the Parkinson’s Disease Questionnaire (PDQ-39). Age Ageing24(6), 505–509 (1995).
   PubMed Web of Science ®Google Scholar
• Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual. Life Res.4(3), 241–248 (1995).
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing26(5), 353–357 (1997).
   PubMed Web of Science ®Google Scholar
• Hagell P, Nygren C. The 39 item Parkinson’s disease questionnaire (PDQ-39) revisited: implications for evidence-based medicine. J. Neurol. Neurosurg. Psychiatry78(11), 1191–1198 (2007).
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson’s disease questionnaire. Psychol. Health12(6), 805– 814 (1997).
   Web of Science ®Google Scholar
• Olanow CW, Schapira AH, LeWitt PA et al. TCH346 as a neuroprotective drug in Parkinson’s disease: a double-blind, randomised, controlled trial. Lancet Neurol.5(12), 990–991 (2006).
   PubMed Web of Science ®Google Scholar
• Antonini A, Isaias IU, Canesi M et al. Duodenal levodopa infusion for advanced Parkinson’s disease: 12-month treatment outcome. Mov. Disord.22(8), 1145–1149 (2007).
   PubMed Web of Science ®Google Scholar
• Deuschl G, Vaitkus A, Fox GC et al. Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing-off. Mov. Disord.22(11), 1550–1555 (2007).
   PubMed Web of Science ®Google Scholar
• Grosset D, Taurah L, Burn DJ et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis. J. Neurol. Neurosurg. Psychiatry78(5), 465–469 (2007).
   PubMed Web of Science ®Google Scholar
• Pahwa R, Stacy MA, Factor SA et al. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology68(14), 1108–1115 (2007).
   PubMed Web of Science ®Google Scholar
• Reuther M, Spottke EA, Klotsche J et al. Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat. Disord.13(2), 108–114 (2007).
   PubMed Web of Science ®Google Scholar
• Zangaglia R, Martignoni E, Glorioso M et al. Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study. Mov. Disord.22(9), 1239–1244 (2007).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Deuschl G. Effect of medical and surgical interventions on health-related quality of life in Parkinson’s disease. Mov. Disord.22(6), 757–765 (2007).
   PubMed Web of Science ®Google Scholar
• Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med.355(9), 896–908 (2006).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick R, Peto V, Jenkinson C, Greenhall R, Hyman N. Health-related quality of life in Parkinson’s disease: a study of outpatient clinical attenders. Mov. Disord.12(6), 916–922 (1997).
   PubMed Web of Science ®Google Scholar
• Martínez Martín P. Calidad de vida relacionada con la salud en la Enfermedad de Parkinson. Medicina stm Editores SL, Barcelona, Spain (2002).
   Google Scholar
• Fitzpatrick R, Norquist JM, Jenkinson C. Distribution-based criteria for change in health-related quality of life in Parkinson’s disease. J. Clin. Epidemiol.57(1), 40–44 (2004).
   PubMed Web of Science ®Google Scholar
• Peto V, Jenkinson C, Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson’s disease questionnaire. Age Ageing30(4), 299–302 (2001).
   PubMed Web of Science ®Google Scholar
• de Boer AGEM, Wijker W, Speelman JD, de Haes JCJM. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J. Neurol. Neurosurg. Psychiatry61(1), 70–74 (1996).
   PubMed Web of Science ®Google Scholar
• Hobson P, Holden A, Meara J. Measuring the impact of Parkinson’s disease with the Parkinson’s Disease Quality of Life Questionnaire. Age Aging28(4), 341–346 (1999).
   PubMed Web of Science ®Google Scholar
• Serrano-Dueñas M, Martinez-Martin P, Vaca-Baquero V. Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV). Parkinsonism Relat. Disord.10(7), 433–437 (2004).
   PubMed Web of Science ®Google Scholar
• de Boer AG, Sprangers MA, Speelman HD, de Haes HC. Predictors of health care use in patients with Parkinson’s disease: a longitudinal study. Mov. Disord.14(5), 772–779 (1999).
   PubMed Web of Science ®Google Scholar
• Rochow SB, Blackwell AD, Brown VJ. Quality of life in Parkinson’s disease: movement disorders clinic vs. general medical clinic – a comparative study. Scott. Med. J.50(1), 18–20 (2005).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Serrano-Dueñas M, Forjaz MJ, Serrano MS. Two questionnaires for Parkinson’s disease: are the PDQ-39 and PDQL equivalent? Qual. Life Res.16(7), 1221–1230 (2007).
   PubMed Web of Science ®Google Scholar
• Reuther M, Spottke EA, Klotsche J et al. Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat. Disord.13(2), 108–114 (2007).
   PubMed Web of Science ®Google Scholar
• Serrano-Dueñas M, Serrano S. Psychometric characteristics of PIMS – compared to PDQ-39 and PDQL- to evaluate quality of life in Parkinson’s disease patients: validation in Spanish (Ecuadorian style). Parkinsonism Relat. Disord.14(2), 126–132 (2008)
   PubMed Web of Science ®Google Scholar
• Pacchetti C, Aglieri R, Mancini F, Martignoni E, Nappi G. Active music therapy and Parkinson’s disease: methods. Funct. Neurol.13(1), 57–67 (1998).
   PubMed Web of Science ®Google Scholar
• Esselink RA, de Bie RM, de Haan RJ et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology62(2), 201–207 (2004).
   PubMed Web of Science ®Google Scholar
• Fraix V, Houeto JL, Lagrange C et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry77(4), 443–449 (2006)
   PubMed Web of Science ®Google Scholar
• Slowinski JL, Putzke JD, Uitti RJ et al. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. J. Neurosurg.106(4), 626–632 (2007).
   PubMed Web of Science ®Google Scholar
• Calne S, Schulzer M, Mak E et al. Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson’s Impact Scale (PIMS). Parkinsonism Relat. Disord.2(2), 55–61 (1996).
   PubMedGoogle Scholar
• Calne SM, Mak E, Hall J et al. Validating a quality-of-life scale in caregivers of patients with Parkinson’s disease: Parkinson’s Impact Scale (PIMS). Adv. Neurol.91, 115–22 (2003)
   PubMedGoogle Scholar
• Schulzer M, Mak E, Calne S. The psychometric properties of the Parkinson’s Impact Scale (PIMS) as a measure of quality of life in Parkinson’s disease. Parkinsonism Relat. Disord.9(5), 291–294 (2003).
   PubMed Web of Science ®Google Scholar
• Ray J, Das SK, Gangopadhya PK, Roy T. Quality of life in Parkinson’s disease – Indian scenario. J. Assoc. Physicians India54, 17–21 (2006).
   PubMedGoogle Scholar
• Pal PK, Thennarasu K, Fleming J, Schulzer M, Brown T, Calne SM. Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson’s disease and in their caregivers. Parkinsonism Relat. Disord.10(3), 157–168 (2004)
   PubMed Web of Science ®Google Scholar
• Brod M, Mendelsohn GA, Roberts B. Patients’ experiences of Parkinson’s disease. J. Gerontology B Psychol. Sci. Soc. Sci.53(4), 213–222 (1998).
   PubMed Web of Science ®Google Scholar
• van den Berg M. Leben mit Parkinson – Entwicklung und psychometrische Testung des Fragenbogens PLQ. Neurol Rehabil.4, 221–226 (1998).
   Google Scholar
• Marinus J, Visser M, Martínez-Martín P, van Hilten JJ, Stiggelbout AM. A short psychosocial questionnaire for patients with Parkinson’s disease: the SCOPA–PS. J. Clin. Epidemiol.56(1), 61–67 (2003).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Martínez-Martín P, Vargas AP. Independent validation of SCOPA–Psychosocial and metric properties of the PDQ-39 Brazilian version. Mov. Disord.22(1), 91–98 (2007).
   PubMed Web of Science ®Google Scholar
• Knudsen K, Martinez-Martin P, Deuschl G. Untersuchung zur Reliabilität und Validität der Deutschen Version eines Fragebogens zur psychosozialen Beeinträchtigung von Parkinsonpatienten (SCOPA–PS). Akt. Neurol.34(5), 267–271 (2007).
   Web of Science ®Google Scholar
• Virués-Ortega J, Carod-Artal FJ, Serrano-Dueñas M et al. Cross-cultural validation of the Scales for Outcomes in Parkinson’s Disease-Psychosocial Questionnaire (SCOPA–PS) in four Latin American countries. Value Health (2008) (Epub ahead of print).
   PubMedGoogle Scholar
• Carod-Artal FJ, Vargas AP, Martinez-Martin P. Determinants of quality of life in Brazilian patients with Parkinson’s disease. Mov. Disord.22(10), 1408–1415 (2007).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Ziomkowski S, Mourão Mesquita H, Martínez-Martin P. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson’s disease. Parkinsonism Relat. Disord.14(2), 102–108 (2008).
   PubMed Web of Science ®Google Scholar
• Marinus J, Visser M, Jenkinson C, Stiggelbout AM. Evaluation of the Dutch version of the Parkinson’s Disease Questionnaire 39. Parkinsonism Relat. Disord.14(1), 24–27 (2008).
   PubMed Web of Science ®Google Scholar
• Ellgring H, Seiler S, Perleth B, Frings W, Gasser T, Oertel W. Psychosocial aspects of Parkinson’s disease. Neurology43(12, Suppl. 6), 41–44 (1993).
   PubMed Web of Science ®Google Scholar
• Spliethoff-Kamminga NGA, Zwinderman AH, Springer MP, Roos RAC. Psychosocial problems in Parkinson’s disease: evaluation of a disease-specific questionnaire. Mov. Disord.18(5), 503–509 (2003).
   PubMed Web of Science ®Google Scholar
• Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J; Parkinson Study Group. Development and testing of the Parkinson’s disease quality of life scale. Mov. Disord.18(6), 637–645 (2003).
   PubMed Web of Science ®Google Scholar
• Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson’s disease. A randomized controlled trial. JAMA284(15), 1931–1938 (2000).
   PubMed Web of Science ®Google Scholar
• Biglan KM, Schwid S, Eberly S et al. Rasagiline improves quality of life in patients with early Parkinson’s disease. Mov.. Disord.21(5), 616–623 (2006).
   PubMed Web of Science ®Google Scholar
• Noyes K, Dick AW, Holloway RG; Parkinson Study Group. Pramipexole versus levodopa in patients with early Parkinson’s disease: effect on generic and disease-specific quality of life. Value Health9(1), 28–38 (2006).
   PubMed Web of Science ®Google Scholar
• Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health-related quality of life in Parkinson’s disease: a systematic review of disease-specific instruments. J. Neurol. Neurosurg. Psychiatry72(2), 241–248 (2002).
   PubMed Web of Science ®Google Scholar
• Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord.21(Suppl. 14), 290–304 (2006).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P. Health-related quality of life in Parkinson’s disease: outcomes of the therapeutic interventions. Expert Rev. Pharmacoeconomics Outcomes Res.1, 99–108 (2001).
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Health Qual. Life Outcomes4, 79 (2006).
   PubMed Web of Science ®Google Scholar
• Revicki DA. FDA draft guidance and health-outcomes research. Lancet369(9561), 540–542 (2007).
   PubMed Web of Science ®Google Scholar
• Revicki DA, Gnanasakthy A, Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier. Qual. Life Res.16(4), 717–723 (2007).
   PubMed Web of Science ®Google Scholar
• Lyons KE, Pahwa R. Electronic motor function diary for patients with Parkinson’s disease: a feasibility study. Parkinsonism Relat. Disord.13(5), 304–307 (2007).
   PubMed Web of Science ®Google Scholar
• Kondraske GV, Stewart RM. Quantitative characterization of disease severity in diseases with complex symptom profiles. Conf. Proc. IEEE Eng. Med. Biol. Soc.1, 3966–3969 (2006).
   Google Scholar
• Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual. Life Res.12(4), 349–362 (2003).
   PubMed Web of Science ®Google Scholar
• Brozek JL, Guyatt GH, Schünemann HJ. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health Qual. Life Outcomes4, 69 (2006).
   PubMed Web of Science ®Google Scholar
• de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual. Life Outcomes4, 54 (2006).
   PubMed Web of Science ®Google Scholar
• Norman GR, Wyrwich KW, Patrick DL. The mathematical relationship among different forms of responsiveness coefficients. Qual. Life Res.16(5), 815–822 (2007).
   PubMed Web of Science ®Google Scholar
• Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual. Life Outcomes.4, 70 (2006).
   PubMed Web of Science ®Google Scholar